Evidence map›Paper›PMID 38139247›Full record

ArticleInternational journal of molecular sciences2023

Effect of

Laura Rojas, Daniel Pardo-Rodriguez, Claudia Urueña, Paola Lasso, Cindy Arévalo, Mónica P Cala, Susana Fiorentino

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Laura RojasGrupo de Inmunobiología y Biología Celular, Pontificia Universidad Javeriana, Bogotá 110211, Colombia.ORCID 0000-0001-6584-8123
Daniel Pardo-RodriguezMetabolomics Core Facility-MetCore, Vicepresidency for Research, Universidad de Los Andes, Bogotá 111711, Colombia.
Claudia UrueñaGrupo de Inmunobiología y Biología Celular, Pontificia Universidad Javeriana, Bogotá 110211, Colombia.
Paola LassoGrupo de Inmunobiología y Biología Celular, Pontificia Universidad Javeriana, Bogotá 110211, Colombia.ORCID 0000-0002-2976-3277
Cindy ArévaloGrupo de Inmunobiología y Biología Celular, Pontificia Universidad Javeriana, Bogotá 110211, Colombia.ORCID 0000-0003-4229-0918
Mónica P CalaMetabolomics Core Facility-MetCore, Vicepresidency for Research, Universidad de Los Andes, Bogotá 111711, Colombia.ORCID 0000-0002-8198-726X
Susana FiorentinoGrupo de Inmunobiología y Biología Celular, Pontificia Universidad Javeriana, Bogotá 110211, Colombia.ORCID 0000-0002-4664-0682
Pontificia Universidad Javeriana · COUniversidad de Los Andes · CO

Funding

Convocatoria Ecosistema Científico-Colombia Científica FP44842-221-2018
6 · The paper itself

Abstract

Previously, studies have shown that leukemic cells exhibit elevated glycolytic metabolism and oxidative phosphorylation in comparison to hematopoietic stem cells. These metabolic processes play a crucial role in the growth and survival of leukemic cells. Due to the metabolic plasticity of tumor cells, the use of natural products has been proposed as a therapeutic alternative due to their ability to attack several targets in tumor cells, including those that could modulate metabolism. In this study, the potential of

Indexed as

Leukemia, MyeloidPhytolaccaceaeHumansK562 CellsPlant ExtractsPlant Extractscell proliferationmyeloid leukemiaPetiveria alliacea aqueous extractuntargeted metabolomics

Identifiers

PMID38139247
PMCPMC10743714
OpenAlexW4389680877

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.